25 LLC’s Inari Medical, Inc. Common Stock NARI Stock Holding History

25 LLC’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7	Closed	-$392	–	595
2023 Q2	$392	Buy	+7	New	+$442	﹤0.01%	599

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

25 LLC's NARI Position: Q3 2023 in Review

25 LLC sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2023, closing a stake of 7 shares — an estimated $392 sold.

25 LLC first reported a position in NARI in Q2 2023 and held it in 1 quarter. The position peaked at $392 in Q2 2023. 250 funds tracked by Wall St. Rank hold NARI as of Q3 2023.

25 LLC reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
25 LLC sold 7 Inari Medical, Inc. Common Stock shares in Q3 2023, an estimated $392.
25 LLC first reported a position in Inari Medical, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
25 LLC's Inari Medical, Inc. Common Stock position peaked at $392 in Q2 2023.
250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.